Ten years too long: strontium ranelate, cardiac events, and the European Medicines Agency.
Department of Medicine, University of Auckland, Private Bag 92 019, Auckland 1142, New Zealand m.bolland@auckland.ac.nz.
Mark J
MJ
Bolland
Department of Medicine, University of Auckland, Private Bag 92 019, Auckland 1142, New Zealand.
Andrew
A
Grey
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002986:Clinical Trials as Topic / Q000592:standards; D004341:Drug Evaluation / Q000592:standards*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D060735:Pharmacovigilance; D013876:Thiophenes / Q000009:adverse effects*; D013997:Time Factors
D050071:Bone Density Conservation Agents; D013876:Thiophenes; C081587:strontium ranelate